Emanuel Paula Magalhães

Emanuel Paula Magalhães

Auto-generated profile, based on publicly available information

Emanuel Paula Magalhães

Universidade Federal do Ceará

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2019 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Closed access
Ramon Róseo Paula Pessoa Bezerra de MenezesRamon Róseo Paula Pessoa Bezerra de Menezes
Ramon Róseo Paula Pessoa Bezerra de Menezes
TSTiago Sampaio
Tiago Sampaio
DLDanya Bandeira Lima
Danya Bandeira Lima
PSPaloma L. Sousa
Paloma L. Sousa
IAIsabella E.P. de Azevedo
Isabella E.P. de Azevedo
AMAlice Maria Costa Martins
Alice Maria Costa Martins

16 January 2023 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
FMFrancisco Rogenio da Silva Mendes
Francisco Rogenio da Silva Mendes
ASAntonio Wlisses da Silva
Antonio Wlisses da Silva
MFMaria Kueirislene Amâncio Ferreira
Maria Kueirislene Amâncio Ferreira
EREmanuela de Lima Rebouças
Emanuela de Lima Rebouças
IBItalo Moura Barbosa
Italo Moura Barbosa
Helcio Silva Dos SantosHelcio Silva Dos Santos
Helcio Silva Dos Santos
The prevalence of anxiety is a significant public health problem, being the 24th leading cause of disability in individuals affected by this disorder. In this context, chalcones, a flavonoid subclass obtained from natural or synthetic sources, interact with central nervous system (CNS) receptors at the same binding site as benzodiazepines, the primary drugs used in the treatment of anxiety. Thus, our study investigates the anxiolytic effect of synthetic chalcones derived from the natural product 2-hydroxy-3,4,6-trimethoxyacetophenone isolated from Croton anisodontus Müll.Arg. in modulating anxiolytic activity via GABAergic and serotoninergic neurotransmission in an adult zebrafish model. Chalcones 1 and 2 were non-toxic to adult zebrafish and showed anxiolytic activity via GABAA receptors. Chalcone 2 also had its anxiolytic action reversed by the antagonist granisetron, indicating the participation of serotonergic receptors 5HTR3A/3B in the anxiolytic effect. In addition, molecular docking results showed that chalcones have a higher affinity for the GABAA receptor than DZP and binding in the same region of the DZP binding site, indicating a similar effect to the drug. Furthermore, the interaction of chalcones with GABAA and 5-HT3A receptors demonstrates the anxiolytic effect potential of these molecules. Communicated by Ramaswamy H. Sarma

19 September 2022 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
CCCarlos Henrique Leitão Cavalcante
Carlos Henrique Leitão Cavalcante
FAFrancisco Wagner Almeida-Neto
Francisco Wagner Almeida-Neto
MRMatheus Nunes da Rocha
Matheus Nunes da Rocha
PBPaulo Nogueira Bandeira
Paulo Nogueira Bandeira
Ramon Róseo Paula Pessoa Bezerra de MenezesRamon Róseo Paula Pessoa Bezerra de Menezes
Ramon Róseo Paula Pessoa Bezerra de Menezes
Helcio Silva Dos SantosHelcio Silva Dos Santos
Helcio Silva Dos Santos
Characterized as a neglected disease, Chagas disease is an infection that, in the current scenario, affects about 8 million people per year, with a higher incidence in underdeveloped countries, Chagas is responsible for physiological disabilities that result in impacts that are slightly reflected in world socioeconomic stability. Although treatments are based on drugs such as Benznidazole, the pathology lacks a continuous treatment method with low toxicological incidence. The present study estimates the anti-chagasic activity of the synthetic chalcone CPN2F based on the alignment between in vitro tests and structural classification in silico studies, molecular docking and ADMET studies. The in vitro tests showed a reduction in the protozoan metabolism in host cells (LLC-MK2). At the same time, the molecular docking models evaluate this growth inhibition through the synergistic effect associated with Benznida- zole against validated therapeutic target key stages (Cruzaine TcGAPDH and Trypanothione reductase) of the Trypanosoma cruzi development cycle. The in silico prediction results reveal an alignment between pharmacokinetic attributes, such as renal absorption and release, which allow the preparation of CPN2F as an antichagasic drug with a low incidence of organic toxicity. Communicated by Ramaswamy H. Sarma

1 January 2021 in Brazilian Archives of Biology and Technology
Verified
Journal Article
Open access
JCJader Almeida Canuto
Jader Almeida Canuto
TSTiago Sampaio
Tiago Sampaio
MSMateus Edson da Silva
Mateus Edson da Silva
MCMac Dionys Rodrigues da Costa
Mac Dionys Rodrigues da Costa
IAIgor Moreira de Almeida
Igor Moreira de Almeida
AMAlice Maria Costa Martins
Alice Maria Costa Martins

1 January 2024 in Brazilian Archives of Biology and Technology
Verified
Journal Article
Open access
PDF file
MPMaria Liliane Luciano Pereira
Maria Liliane Luciano Pereira
MCMac Dionys Rodrigues da Costa
Mac Dionys Rodrigues da Costa
GVGlautemberg de Almeida Viana
Glautemberg de Almeida Viana
EMEmanuel Paula Magalhães
Emanuel Paula Magalhães
BDBruna Ribeiro Duque
Bruna Ribeiro Duque
TSTiago Sampaio
Tiago Sampaio
Diabetes mellitus (DM) is a major cause of chronic kidney disease (CKD) and changes in lipoprotein. Literature data suggest that cholesterol associated with high-density lipoprotein (HDLc) plays a protective role against albuminuria and diabetic nephropathy. These factors are related with changes in serum apolipoproteins such Apo A-I. This work aims to evaluate the correlation of apolipoprotein A-I with renal function in diabetic outpatients. Samples were collected from 281 outpatients for analyses of glycated hemoglobin (HbA1c), serum creatinine (SCr), urea (BUN), cholesterol (TC), triglycerides (TG), HDL-cholesterol (HDLc) and estimation of glomerular filtration rate (eGFR). Urinary samples were obtained to assess urine albumin creatinine ratio (UACR). Triglyceride-glucose index (TyG) was calculated to estimate insulin resistance. The mean age was 61,5 ± 16,4 years. Most patients were female, Afro-Mestizo and over 50 years of age. Pearson's revealed negative correlation of creatinine with HDLc and Apo A-I. There was a correlation of eGFR with HbA1c, TG and HDLc. TyG presented a negative correlation with Apo A-I and HDLc. The highest quartiles of UACR presented the highest TyG and the lowest Apo A-I. In conclusion, Apo A-I indicated an association with insulin resistance and changes in renal function parameters, especially as a factor associated with the onset of albuminuria, with a better predictive potential than the HDLc.

4 November 2022 in Brazilian Journal of Medical and Biological Research
Verified
Journal Article
Open access
PAP.E.A. Aquino
P.E.A. Aquino
ESE.A. de Siqueira
E.A. de Siqueira
LPL.C.F. Paes
L.C.F. Paes
EME.P. Magalhães
E.P. Magalhães
TBT.M. Barbosa
T.M. Barbosa
GVGLAUCE VIANA
GLAUCE VIANA
Glial cells have been implicated in temporal lobe epilepsy in humans and in its models. Astrocytes are lost in several brain regions after acute seizures induced by pilocarpine and may suffer hyperplasia at subsequent time points. This study investigated the effect of N-methyl-(2S,4R)-trans-4-hydroxy-L-proline (NMP) on astrocytes exposed to cytotoxic concentrations of pilocarpine. Astrocytes were incubated with pilocarpine (half maximal inhibitory concentration (IC50)=31.86 mM) for 24 h. Afterwards, they were treated with NMP at concentrations ranging from 3.12 to 100 μg/mL for 24 h. Cell viability was assessed by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Cytoplasmic reactive oxygen species (ROS) and mitochondrial transmembrane potential (ΔΨm) were analyzed by flow cytometry using 2',7'-dichlorofluorescein diacetate (DCFH-DA) and rhodamine-123 (Rho123), respectively. Expression of glial fibrillary acidic protein (GFAP) and voltage-dependent anion channel-1 (VDAC-1) were measured by western blot. Pilocarpine significantly decreased cell viability and mitochondrial potential and increased ROS concentration significantly by 6.7 times compared to the control. NMP concentrations ≥25 µg/mL protected astrocytes against pilocarpine-induced injury in a concentration-dependent manner. Concomitantly, NMP reduced cytoplasmic ROS accumulation to 27.3, 24.8, and 12.3% in the groups treated with 25, 50, and 100 µg/mL NMP, respectively. NMP also protected mitochondria from pilocarpine-induced depolarization. These effects were associated with improvement of pilocarpine-induced GFAP and VDAC-1 overexpression, which are important biomarkers of astrocyte dysfunction. In conclusion, the improvement of ROS accumulation, VDAC-1 overexpression, and mitochondrial depolarization are possible mechanisms of the NMP protective action on reactive astrocytes.